Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

Item

http://www.wikidata.org/entity/Q36677787

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@ast

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@en

type

Item

label

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@ast

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@en

prefLabel

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@ast

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@en

P1476

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

@en

P2093

Afshin Dowlati

http://www.w3.org/2001/XMLSchema#string

Beth A Overmoyer

http://www.w3.org/2001/XMLSchema#string

Charles L Hoppel

http://www.w3.org/2001/XMLSchema#string

Eleanor G Zuhowski

http://www.w3.org/2001/XMLSchema#string

Joanna M Brell

http://www.w3.org/2001/XMLSchema#string

Joseph Gibbons

http://www.w3.org/2001/XMLSchema#string

Karen C Weaver

http://www.w3.org/2001/XMLSchema#string

Mark D Schluchter

http://www.w3.org/2001/XMLSchema#string

Matthew M Cooney

http://www.w3.org/2001/XMLSchema#string

Merrill J Egorin

http://www.w3.org/2001/XMLSchema#string

P2860

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.

Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

P2888

s00280-008-0754-2

P304

441-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-008-0754-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18414865

http://www.w3.org/2001/XMLSchema#string

P932

4788493

http://www.w3.org/2001/XMLSchema#string